Home Blog Page 232

Blog

Pharma Marketing Blog

Most popular

FDA’s Reprint Distribution Guidelines are “Counterintuitive” & “Indecent”

Pharma Guy - March 23, 2015

Lilly vs. AstraZeneca on Covering the Medicare “Doughnut Hole” Gap

Pharma Guy - October 4, 2010

Let’s Make it a Threesome: One Other Social Media Activity Pharma...

Pharma Guy - June 5, 2009

Boost Post vs Creating Ads on Facebook

Claudia Barbiero - July 13, 2023

Pfizer Flips. Jarvik Flops!

Pharma Guy - February 25, 2008

IOM Report Calls for DTC Moratorium

Pharma Guy - September 25, 2006

Are Women Execs Ready to Break Through the Drug Industry’s “Glass...

Pharma Guy - June 18, 2016

Insurers “Duped” by Deceptive Low-T #Pharma Marketing

Pharma Guy - November 7, 2014

Shared Detail Appointments Can Save Doctors’ Time & Improve Product Education

Pharma Guy - June 14, 2009

Happy Anniversary! First Ever Pharmaguy Social Media Procrastinator Award Goes to…

Pharma Guy - November 12, 2012

1...231232233...240 Page 232 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026